Table 2 |
||||||
|
Expression profile of circulating tumor cells in breast cancer patients compared with the primary tumor |
||||||
|
Circulating tumor cells |
Primary tumor (n = 58) |
Concordance (%) |
||||
|
|
||||||
|
n |
n |
% |
n |
% |
||
|
|
||||||
|
ER-positive |
48 |
12 |
25 |
45 |
78 |
29 |
|
PR-positive |
48 |
2 |
2 |
41 |
71 |
25 |
|
HER2-positive |
58 |
22 |
38 |
9 |
16 |
53 |
|
Muc-1-positive |
58 |
31 |
53 |
- |
- |
- |
|
GA 73.3-positive |
58 |
32 |
55 |
- |
- |
- |
|
|
||||||
|
ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor. |
||||||
|
Fehm et al. Breast Cancer Research 2009 11:R59 doi:10.1186/bcr2349 |
||||||
